Recent Advances in the Management of Insomnia: New Considerations in Treatment Strategies

A continuing medical education activity provided by NAMCP and AAMCN

This activity is an archive from the live session from the 2020 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from February 1, 2021 to March 1, 2022
 

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Eisai

Description:
Insomnia is a sleep disorder which makes it difficult to fall asleep or stay asleep, even when a person has the chance to do so. This can affect a person’s sleep so much that they still feel tired after they wake up. Lack of sleep can sap your energy level, affects your mood, and causes stress with your health, work performance and quality of life. If not treated properly, insomnia can lead to other adverse effects such as anxiety, depression, irritability, concentration and memory problems, poor immune system function, and reduced reaction time. Many adults experience acute insomnia, which last for days or weeks and is usually the result of stress or a traumatic event in one’s life. Some experience chronic insomnia which can last for a month or more. There are 60 million Americans affected by the disease and about 25% of them experience acute insomnia each year, with around 10% experiencing chronic insomnia.

There are several different approaches to the diagnosis of insomnia although there is no definitive test for it. Tools used for diagnosing the disease include a sleep log, which tracks the details of a person’s sleep, sleep inventory of sleeping patterns, blood tests and undergoing a sleep study. These tests help determine the level of insomnia and what treatment plan should be utilized. Insomnia continues to be underdiagnosed and undertreated. Identifying sleep hygiene issues can raise awareness of sleep patterns that need to be changed. Cognitive behavioral therapy has proven efficacy as first-line treatment for insomnia. This can include stimulus control therapy, relaxation techniques, and sleep restriction. However, there are some patients that do not respond to nonpharmacologic treatments and they need to supplement a patient’s nonpharmacologic treatment with a pharmacologic agent. There are currently new treatments that are in clinical trials, including a dual orexin receptor antagonist, which will help regulate sleep by dampening wakefulness without stopping the ability to awaken the external stimuli.

Upon completion of this activity, participants will be able to:

• Discuss the current guideline recommendations for the treatment and management of insomnia to help inform appropriate treatment decisions

• Assess clinical data and outcomes measures for optimal diagnostic testing for patients with insomnia

• Examine the clinical data for the safety and efficacy profiles for pharmacologic therapies for the treatment of insomnia

• Describe the current and emerging treatment considerations for insomnia, including ways to manage residual effects

• Analyze the challenges associated with treatment and managing insomnia, including patient adherence and untreated insomnia
  
   

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)^TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from Eisai

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue